Baron Funds released its Q2 2025 investor letter, showing a 22.7% return for the Baron Global Advantage Fund. Illumina, Inc. (NASDAQ: ILMN) was highlighted in the letter, despite recent challenges. Illumina stock closed at $98.44 per share on August 4, 2025, with a market cap of $15.583 billion. The fund added to its position in Illumina due to its dominant position in DNA sequencing tools.

In Q2 2025, Baron Global Advantage Fund emphasized Illumina, Inc. (NASDAQ: ILMN) in its investor letter. Illumina, a leader in genetic analysis solutions, faced pressures like pricing and geopolitical tensions. Despite challenges, the fund increased its stake in Illumina, believing in its long-term potential. The stock closed at $98.44 per share on August 4, 2025.

Illumina, Inc. (NASDAQ: ILMN) was discussed in the Q2 2025 investor letter by Baron Global Advantage Fund. The stock faced challenges like pricing pressure and geopolitical tensions but remains a top pick for the fund. Illumina stock closed at $98.44 per share on August 4, 2025, with a market cap of $15.583 billion. The fund believes in Illumina’s potential despite recent hurdles.

Read more at Yahoo Finance: Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors?